Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | GABRP | O00591 | 2/20 | 0.42 |
| ▸ | GABRD | O14764 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10652610 | 0.89 | CYP3A4 (0.56) | LMNACYP3A4CHRM1CYP2D6CYP1A2 | |
| SCHEMBL29784613 | 0.81 | TSHR (0.59) | CYP3A4ALDH1A1KDM4EHTTHSD17B10 | |
| SCHEMBL1752995 | 0.78 | ACHE (0.43) | LMNACYP3A4CHRM1CYP2D6CYP1A2 | |
| SCHEMBL31575694 | 0.75 | TSHR (0.40) | LMNACYP3A4CHRM1CYP2D6CYP1A2 | |
| SCHEMBL15441449 | 0.71 | TRPV4 (0.64) | LMNAALDH1A1KDM4EHPGDHTT | |
| SCHEMBL10691334 | 0.71 | TSHR (0.47) | LMNACYP3A4CNR1ALDH1A1KDM4E | |
| SCHEMBL10681618 | 0.71 | KDM4E (0.46) | CYP3A4ALDH1A1KDM4EHPGDHTT | |
| SCHEMBL1754562 | 0.70 | ACHE (0.61) | LMNACYP3A4CHRM1CYP2D6CYP1A2 | |
| Hydrochloric Acid SCHEMBL10468401 | 0.68 | ADORA2A (0.49) | LMNACYP3A4CHRM1CYP2D6CYP1A2 | |
| SCHEMBL5651101 | 0.68 | CYP2D6 (0.54) | LMNACYP3A4CHRM1CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122082007-A | Preparation method and application of copper-silver electrocatalyst for preparing ethylene oxide | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260092382-A1 | ELECTRODE, ELECTROCHEMICAL CELL, AND METHOD OF USE THEREOF | UNIV HONG KONG POLYTECHNIC (CN) | 2026-04-02 | — | — | US | disclosed |
| EP-4717799-A1 | ELECTRODE, ELECTROCHEMICAL CELL, AND METHOD OF USE THEREOF | The Hong Kong Polytechnic University (HK) | 2026-04-01 | — | — | EP | disclosed |
| CN-113498405-B | Doped semiconductor nanocrystals, methods of making and using the same | 法国原子能源和替代能源委员会 | 2025-02-25 | — | — | CN | disclosed |
| US-20240226269-A9 | POLYPEPTIDES MIMICKING MPER AND V3-LOOP HIV-1 ENV GLYCOPROTEIN EPITOPES | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2024-07-11 | — | — | US | disclosed |
| US-20240131147-A1 | POLYPEPTIDES MIMICKING MPER AND V3-LOOP HIV-1 ENV GLYCOPROTEIN EPITOPES | UNIV PALACKEHO (CZ) | 2024-04-25 | — | — | US | disclosed |
| US-11905446-B2 | Doped semiconductor nanocrystals, method for preparing same and uses thereof | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2024-02-20 | — | — | US | disclosed |
| EP-4298119-A1 | POLYPEPTIDES MIMICKING MPER AND V3-LOOP HIV-1 ENV GLYCOPROTEIN EPITOPES | Univerzita Palackého v Olomouci (CZ) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023173819-A1 | FOAMED LOW-DENSITY LIGHT DIFFUSION PLATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 成都金发科技新材料有限公司 | 2023-09-21 | — | — | WO | disclosed |
| CN-114750492-B | Foaming low-density light diffusion plate and preparation method and application thereof | 成都金发科技新材料有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-110018117-B | Method for measuring adhesion strength | 日本碍子株式会社 | 2023-05-12 | — | — | CN | disclosed |
| CN-115537632-A | Titanium-nickel-iron-based alloy material and preparation method thereof | 河源粤奥硬质合金有限公司 | 2022-12-30 | — | — | CN | disclosed |
| WO-2022179648-A1 | POLYPEPTIDES MIMICKING MPER AND V3-LOOP HIV-1 ENV GLYCOPROTEIN EPITOPES | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2022-09-01 | — | — | WO | disclosed |
| EP-4050025-A1 | POLYPEPTIDES MIMICKING MPER AND V3-LOOP HIV-1 ENV GLYCOPROTEIN EPITOPES | Biotechnologicky ustav AV CR, v.v.i. (CZ) | 2022-08-31 | — | — | EP | disclosed |
| CN-114750492-A | Foamed low-density light diffusion plate and preparation method and application thereof | 成都金发科技新材料有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-216120312-U | IBC structure gallium antimonide thermophotovoltaic cell | 兰州大学 | 2022-03-22 | — | — | CN | disclosed |
| US-20220064525-A1 | DOPED SEMICONDUCTOR NANOCRYSTALS, METHOD FOR PREPARING SAME AND USES THEREOF | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2022-03-03 | — | — | US | disclosed |
| CN-114085446-A | Creep-resistant composite material and preparation method thereof | 四川大学 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092382-A1 | ELECTRODE, ELECTROCHEMICAL CELL, AND METHOD OF USE THEREOF | SOD1, CD2, SOD3 | LMNA 4534/4885CYP3A4 2574/4885CHRM1 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.